Medical Staff Pulse is
a Publication of the Chief of Staff
Physician News

Jeffrey N. Wilkins, M.D., Receives Endowed Chair in Addiction Medicine

Jeffrey N. Wilkins, M.D., received the Lincy Foundation/Andrew Heyward-Amy Moynihan Endowed Chair in Addiction Medicine at Cedars-Sinai on January 24. Wilkins is the inaugural holder of the chair, which will fund research and teaching efforts focused on the causes and treatments for addiction.

Wilkins is vice chair of the Department of Psychiatry and Behavioral Neurosciences, as well as director of Addiction Medicine at Cedars-Sinai. He is also director of Addiction Studies within the department's Clinical Trials Unit and program director for the ACGME-approved Fellowship in Addiction Psychiatry. In addition, Wilkins serves as Adjunct Professor of Psychiatry and Behavioral Sciences at the David Geffen School of Medicine at UCLA.

(Pictured l-r) Jeffrey Wilkins, M.D., is congratulated by John C. Law, chairman of the Board of Directors, and Shlomo Melmed, M.D., senior vice president of Academic Affairs.

As an addiction expert and prolific researcher, Wilkins has published hundreds of papers in medical and psychiatric journals on topics that include the treatment and prevention of substance abuse in adults, adolescents and children, the pharmakinetics of abused substances, and the identification of biological markers for addiction and psychiatric disorders.

"The endowed chair we inaugurate today will shine the light of science on the mysteries of addiction," said John C. Law, chairman of the Board of Directors, during his opening remarks at the event. "In our time, the understanding of this disease will grow. It will evolve into new approaches and treatments. Fewer lives will be damaged -- and fewer hearts will be broken."

The chair is funded jointly by the Lincy Foundation, a non-profit formed by Kirk Kerkorian's company Tracinda Corporation; Andrew Heyward, chairman and chief executive officer of DIC Entertainment, and Amy Moynihan, vice president of marketing at the Los Angeles Times.